Vistra Corp.: Form 10-K for the period ended Dec 31, 2025
Filed with the SEC on Feb 27, 2026 and accepted by EDGAR at Feb 27, 2026, 01:27 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2025-01-01 to 2025-12-31 | $17.59bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Selling, general and administrative | 12 months2025-01-01 to 2025-12-31 | $1.71bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2025-01-01 to 2025-12-31 | $1.91bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2025-01-01 to 2025-12-31 | $1.18bn | us-gaap:InterestExpenseNonoperating |
| Income tax | 12 months2025-01-01 to 2025-12-31 | $179.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2025-01-01 to 2025-12-31 | $944.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2025-01-01 to 2025-12-31 | $2.18 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2025-01-01 to 2025-12-31 | $2.22 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2025-01-01 to 2025-12-31 | 345,656,067 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2025-01-01 to 2025-12-31 | $4.07bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2025-01-01 to 2025-12-31 | $2.75bn | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2025-01-01 to 2025-12-31 | $306.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months2025-01-01 to 2025-12-31 | $1.03bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2025-12-31 | $785.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-12-31 | $9.18bn | us-gaap:AssetsCurrent |
| Total assets | At period end2025-12-31 | $41.55bn | us-gaap:Assets |
| Current liabilities | At period end2025-12-31 | $11.81bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-12-31 | $36.44bn | us-gaap:Liabilities |
| Long-term debt | At period end2025-12-31 | $17.04bn | us-gaap:LongTermDebt |
| Short-term borrowings | At period end2025-12-31 | $1.80bn | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2025-12-31 | $5.10bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001692819-26-000006. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.